The Arab Drug Company (EGX: ADCI)
Egypt
· Delayed Price · Currency is EGP
103.27
0.00 (0.00%)
At close: Oct 14, 2024
The Arab Drug Company Revenue
In the fiscal year ending June 30, 2024, The Arab Drug Company had annual revenue of 785.52M EGP with 23.95% growth. The Arab Drug Company had revenue of 204.44M in the quarter ending June 30, 2024, with 37.59% growth.
Revenue
785.52M
Revenue Growth
+23.95%
P/S Ratio
0.78
Revenue / Employee
684.25K
Employees
1,148
Market Cap
609.96M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 785.52M | 151.79M | 23.95% |
Jun 30, 2023 | 633.73M | 128.69M | 25.48% |
Jun 30, 2022 | 505.04M | -32.01M | -5.96% |
Jun 30, 2021 | 537.05M | 16.25M | 3.12% |
Jun 30, 2020 | 520.80M | 84.45M | 19.35% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition